quinazolines has been researched along with Female Genital Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, T; Berlin, S; Campos, SM; Horowitz, N; Krasner, CN; Lee, H; Lou, W; Meegan, K; Penson, RT; Pereira, L; Tyburski, K; Whalen, C | 1 |
| Annunziata, CM; Botesteanu, DA; Cao, L; Cimino-Mathews, A; Figg, WD; Harrell, MI; Ho, TW; Houston, N; Kohn, EC; Lee, JM; Lipkowitz, S; Nguyen, J; Ogurtsova, A; Peer, CJ; Swisher, EM; Taube, JM; Thompson, E; Xu, H; Zimmer, A | 1 |
| Chen, XG; Feng, ZQ; Li, J; Liu, Y; Meng, Y | 1 |
| Atkinson, T; Berlin, ST; Bunnell, CA; Campos, SM; Chen, WY; Harris, L; Hirsch, MS; Krasner, CN; Lee, J; Matulonis, U; Parker, LM | 1 |
| Cserepes T, M; Döme, B; Rényi-Vámos, F; Török, S | 1 |
| Barrick, B; Fraga, G; Matthys, B | 1 |
| Chon, HS; Hu, W; Kavanagh, JJ | 1 |
| Daud, A; Munster, P; Spriggs, DR | 1 |
3 review(s) available for quinazolines and Female Genital Neoplasms
| Article | Year |
|---|---|
[Nintedanib (BIBF 1120) in the treatment of solid cancers: an overview of biological and clinical aspects].
Topics: Animals; Antineoplastic Agents; Axitinib; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Colorectal Neoplasms; Digestive System; Enzyme Inhibitors; Female; Genital Neoplasms, Female; Humans; Imidazoles; Indazoles; Indoles; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms; Niacinamide; Oligonucleotides; Phenylurea Compounds; Phthalazines; Piperidines; Prostatic Neoplasms; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Quinazolines; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sorafenib; Sulfonamides; Xenograft Model Antitumor Assays | 2012 |
Targeted therapies in gynecologic cancers.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gefitinib; Gene Transfer Techniques; Genital Neoplasms, Female; Humans; Neovascularization, Pathologic; Oligonucleotides, Antisense; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Receptor, ErbB-2; Signal Transduction; Thalidomide; Thionucleotides; Trastuzumab | 2006 |
New drugs in gynecologic cancer.
Topics: Aminopyridines; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Boronic Acids; Bortezomib; Cisplatin; Female; Gefitinib; Genital Neoplasms, Female; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Organoplatinum Compounds; Paclitaxel; Protein-Tyrosine Kinases; Pyrazines; Quinazolines; Trastuzumab | 2001 |
3 trial(s) available for quinazolines and Female Genital Neoplasms
| Article | Year |
|---|---|
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Genital Neoplasms, Female; Humans; Quinazolines; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escala
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Humans; Lymphocytes, Tumor-Infiltrating; Middle Aged; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Quinazolines; Vascular Endothelial Growth Factor Receptor-1 | 2017 |
Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boston; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Gefitinib; Genital Neoplasms, Female; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Quinazolines; Salvage Therapy; Time Factors; Treatment Outcome | 2010 |
2 other study(ies) available for quinazolines and Female Genital Neoplasms
| Article | Year |
|---|---|
F84, a quinazoline derivative, exhibits high potent antitumor activity against human gynecologic malignancies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Body Weight; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; ErbB Receptors; Female; Genital Neoplasms, Female; Humans; Mice; Mitogen-Activated Protein Kinases; Organ Size; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Xenograft Model Antitumor Assays | 2010 |
Ulcerated plaques in the pelvic region of an adult female.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Female; Fluorouracil; Genital Neoplasms, Female; Humans; Lapatinib; Middle Aged; Neoplasm Invasiveness; Quinazolines; Skin Neoplasms; Skin Ulcer | 2012 |